Pharmacogenomics & Personalized Medicine

Papers
(The H4-Index of Pharmacogenomics & Personalized Medicine is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy27
Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China24
Construction and Validation of a Novel Nomogram for Predicting the Recurrence of Diffuse Large B Cell Lymphoma Treated with R-CHOP20
One Rare Warfarin Resistance Case and Possible Mechanism Exploration19
Genetic Landscape of VIP Pharmacogenomic Variants in the Kinh Vietnamese Population19
Integrated Bioinformatics Analysis and Experimental Verification of Immune Cell Infiltration and the Related Core Genes in Ulcerative Colitis18
Clinical Characteristics and Gene Mutations of Two Families with MODY 3 in Inner Mongolia17
The Role of Single Nucleotide Polymorphisms in Transporter Proteins and the Folate Metabolism Pathway in Delayed Methotrexate Excretion: A Case Report and Literature Review13
Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer12
A Case-Control Study of the Relationship Between Genetic Polymorphism and Cretinism in Xinjiang11
Challenges in DPYD Test Implementation in Patients Treated with Fluoropyrimidines are DPYD Genotype Arriving on Time? [Letter]11
Berberine Repairs Intestinal Mucosal Barrier by Targeting HSP90AA1 and MAPK1411
0.12535095214844